Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Prepaid Assets: 2022-2025

Historic Prepaid Assets for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to $321,747.

  • InMed Pharmaceuticals' Prepaid Assets rose 28.80% to $191,755 in Q3 2025 from the same period last year, while for Sep 2025 it was $191,755, marking a year-over-year increase of 28.80%. This contributed to the annual value of $321,747 for FY2025, which is 32.65% down from last year.
  • As of FY2025, InMed Pharmaceuticals' Prepaid Assets stood at $321,747, which was down 32.65% from $477,749 recorded in FY2024.
  • InMed Pharmaceuticals' Prepaid Assets' 5-year high stood at $797,225 during FY2022, with a 5-year trough of $321,747 in FY2025.
  • In the last 3 years, InMed Pharmaceuticals' Prepaid Assets had a median value of $477,749 in 2024 and averaged $432,510.
  • Data for InMed Pharmaceuticals' Prepaid Assets shows a maximum YoY crashed of 37.53% (in 2023) over the last 5 years.
  • InMed Pharmaceuticals' Prepaid Assets (Yearly) stood at $797,225 in 2022, then tumbled by 37.53% to $498,033 in 2023, then fell by 4.07% to $477,749 in 2024, then tumbled by 32.65% to $321,747 in 2025.